Jiangxi Sanxin Medtec Co.,Ltd. (SHE:300453)
China · Delayed Price · Currency is CNY 9.28
+0.17 (1.87%)
Sep 14, 2026, 3:04 PM CST
Jiangxi Sanxin Medtec Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,712 | 1,636 | 1,497 | 1,296 | 1,334 | 1,164 |
Other Revenue | 4.29 | 4.02 | 3.85 | 3.66 | 2.38 | - |
| 1,716 | 1,640 | 1,500 | 1,300 | 1,336 | 1,164 | |
Revenue Growth | 8.97% | 9.31% | 15.41% | -2.69% | 14.75% | 23.81% |
Cost of Revenue | 1,094 | 1,056 | 972.05 | 847.27 | 886.52 | 763.96 |
Gross Profit | 621.99 | 584.1 | 528.39 | 452.79 | 449.49 | 400.33 |
Selling, General & Admin | 202.44 | 200.44 | 192.01 | 169.71 | 193.43 | 158.38 |
Research & Development | 81.62 | 75.28 | 63.98 | 51.07 | 40.85 | 42.15 |
Other Operating Expenses | 21.04 | 9.1 | 5.15 | 9.21 | 10.24 | 11.12 |
Operating Expenses | 311.65 | 288.98 | 265.17 | 230.83 | 245.57 | 213.34 |
Operating Income | 310.34 | 295.12 | 263.22 | 221.96 | 203.91 | 186.98 |
Interest Expense | -1.99 | -1.82 | -3.11 | -4.52 | -2.95 | -2.08 |
Interest & Investment Income | 12.43 | 11.69 | 12.44 | 16.01 | 5.71 | 2.13 |
Currency Exchange Gain (Loss) | -2.11 | 1.31 | 2.92 | 0.76 | 1.57 | 1.78 |
Other Non Operating Income (Expenses) | -1.39 | -0.78 | -0.23 | -1.15 | -1.09 | -4.62 |
EBT Excluding Unusual Items | 317.28 | 305.53 | 275.24 | 233.06 | 207.16 | 184.19 |
Gain (Loss) on Sale of Investments | -1.11 | 0.11 | -11.02 | 1.3 | 1.17 | -0.46 |
Gain (Loss) on Sale of Assets | -0.65 | -0.85 | 0.19 | 0.16 | 0.01 | -0.89 |
Asset Writedown | -6.17 | -1.69 | -1.1 | -0.38 | -6.71 | -3.22 |
Other Unusual Items | 32.66 | 21.15 | 12.75 | 18.64 | 23.99 | 15.76 |
Pretax Income | 342.01 | 324.24 | 276.06 | 252.77 | 225.61 | 195.37 |
Income Tax Expense | 33.87 | 33.97 | 28.36 | 29.54 | 26.52 | 23.56 |
Earnings From Continuing Operations | 308.13 | 290.27 | 247.7 | 223.23 | 199.1 | 171.81 |
Minority Interest in Earnings | -26.2 | -25.33 | -20.3 | -16.6 | -14.46 | -15.9 |
Net Income | 281.94 | 264.94 | 227.4 | 206.63 | 184.63 | 155.91 |
Net Income to Common | 281.94 | 264.94 | 227.4 | 206.63 | 184.63 | 155.91 |
Net Income Growth | 19.32% | 16.50% | 10.05% | 11.92% | 18.42% | 34.84% |
Shares Outstanding (Basic) | 518 | 518 | 515 | 518 | 515 | 507 |
Shares Outstanding (Diluted) | 518 | 518 | 516 | 519 | 515 | 513 |
Shares Change | 0.05% | 0.36% | -0.53% | 0.71% | 0.35% | -0.53% |
EPS (Basic) | 0.54 | 0.51 | 0.44 | 0.40 | 0.36 | 0.31 |
EPS (Diluted) | 0.54 | 0.51 | 0.44 | 0.40 | 0.36 | 0.30 |
EPS Growth | 19.26% | 16.08% | 10.64% | 11.13% | 18.00% | 35.56% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | 195.39 | 218.73 | 172.05 | 52.34 | 191.62 | 154.91 |
Free Cash Flow Per Share | 0.38 | 0.42 | 0.33 | 0.10 | 0.37 | 0.30 |
Dividend Per Share | 0.300 | 0.300 | 0.300 | 0.115 | 0.115 | 0.115 |
Dividend Growth | 0% | 0% | 159.97% | 0% | 0% | 12.58% |
Gross Margin | 36.24% | 35.61% | 35.22% | 34.83% | 33.64% | 34.38% |
Operating Margin | 18.08% | 17.99% | 17.54% | 17.07% | 15.26% | 16.06% |
Profit Margin | 16.43% | 16.15% | 15.16% | 15.89% | 13.82% | 13.39% |
Free Cash Flow Margin | 11.39% | 13.34% | 11.47% | 4.03% | 14.34% | 13.31% |
EBITDA | 434.47 | 414.14 | 352.76 | 294.72 | 267.06 | 242.54 |
EBITDA Margin | 25.32% | 25.25% | 23.51% | 22.67% | 19.99% | 20.83% |
D&A For EBITDA | 124.13 | 119.02 | 89.54 | 72.76 | 63.14 | 55.55 |
EBIT | 310.34 | 295.12 | 263.22 | 221.96 | 203.91 | 186.98 |
EBIT Margin | 18.08% | 17.99% | 17.54% | 17.07% | 15.26% | 16.06% |
Effective Tax Rate | 9.90% | 10.48% | 10.27% | 11.68% | 11.75% | 12.06% |
Revenue as Reported | 1,716 | 1,640 | 1,500 | 1,300 | 1,336 | 1,164 |
Advertising Expenses | - | 8.68 | 7.52 | 1.97 | 4.66 | 8.16 |